ATI

ATI · NYSE

$183.07−$6.21 (−3.28%)TodayMarket closed ·
Prev close $189.28

ATI analyst rating

BuyConsensus of 9 analysts over the last 12 months. 100% rate it a buy.
  • Strong buy0
  • Buy9
  • Hold0
  • Underperform0
  • Sell0

12-month price target · 12 analysts

Average $252.55 (+38.0% upside)

Low
$216.48
Now
$183.07
High
$283.50

Upgrades and downgrades

The latest rating actions, newest first

ATI analyst upgrades, downgrades and rating actions
FirmDateActionRating
KeybancOct 8, 2026MaintainsOverweight
Wells FargoSep 30, 2026MaintainsOverweight
KeybancAug 12, 2026MaintainsOverweight
SusquehannaAug 7, 2026MaintainsPositive
BTIGAug 7, 2026MaintainsBuy
TD CowenJul 13, 2026MaintainsBuy
SusquehannaJul 9, 2026MaintainsPositive
KeybancJun 30, 2026MaintainsOverweight
KeybancMay 4, 2026MaintainsOverweight
JP MorganMay 1, 2026MaintainsOverweight

The case for and against

Updated Oct 18, 2026

Bull case

ATI is benefiting from a sharper mix shift toward higher-margin aerospace and defense work, with 2Q26 AA&S sales up 34% Y/Y and Defense up 90% Y/Y, while record backlog of $4.4B and extended lead times support durable demand. Management’s confidence in 2027 is reinforced by rising estimates, with EBITDA now seen at $1.38B and a 24.8% margin, plus a customer-supported VIM investment that should add 15-20% to nickel capacity by early 2028 and deepen its moat in superalloys. The unwind of lower-margin commodity stainless, improving operating leverage, and strong free cash flow conversion provide room for buybacks and further growth projects, making the business look more like a specialized A&D and energy supplier than a cyclical metals producer.

Bear case

ATI is exposed to meaningful cyclical and macro risks that can pressure earnings, including volatility in aerospace and energy demand, LME nickel and titanium input costs, U.S. dollar swings, and geopolitical exposure from foreign ventures. Its reliance on High-Performance Materials, while beneficial in stronger end markets, concentrates performance in aerospace and defense and leaves results vulnerable if those cycles soften, especially given the company’s majority U.S. revenue base and global operating footprint. The mention of a JV impairment charge of 11.4 underscores execution and capital-allocation risk, supporting a cautious fundamental view despite its downstream exposure and diversified alloy mix.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.